Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2006 050 811.5 |
96 | EP file number | EAKZ | 11 16 2681.8 |
97 | EP publication number | EPN | 2397156 |
54 | Designation/title | TI | Verfahren und Zusammensetzungen zur Behandlung persistenter Infektionen und Krebs mittels Hemmung des programmierten 1 (PD-1)-Zelltodweges |
51 | IPC main class | ICM (ICMV) | A61K 31/713 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 38/17 (2006.01), A61K 39/00 (2006.01), C07K 16/28 (2006.01), G01N 33/50 (2006.01), G01N 33/574 (2006.01) |
22 | DE application date | DAT | Jun 8, 2006 |
96 | EP application date | EAT | Jun 8, 2006 |
43 | Date of first publication | OT | Dec 21, 2011 |
| Date of publication of grant | PET | Nov 2, 2016 |
71/73 | Applicant/owner | INH | Dana-Farber Cancer Institute, Boston, Mass., US; EMORY University, Atlanta, Ga., US; The Brigham and Women's Hospital, Inc., Boston, Mass., US; The President and Fellows of Harvard College, Cambridge, Mass., US |
72 | Inventor | IN | Barber, Daniel, North Bethesda, MD 20852, US; Wherry, E. John, Havertown, Pennsylvania 19083, US; Freeman, Gordan, Brookline, MA 02445, US; Sharpe, Arlene, Brookline, MA 02445, US; Dorfman, David M., Brookline, MA 02445, US; Ahmed, Rafi, Atlanta, GA 30307, US |
74 | Representative | VTR | WEIDNER STERN JESCHKE Patentanwälte Partnerschaft mbB, 28359 Bremen, DE |
| Address for service | | WEIDNER STERN JESCHKE Patentanwälte Partnerschaft mbB, 28359 Bremen, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 688872 P Jun 8, 2005
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002397156 Searchable text:
EP000002397156 Original document:
EP000002397156B1 Searchable text:
EP000002397156B1 |
43 | Date of first publication | EVT | Dec 21, 2011 |
| Date of the first transfer into DPMAregister | EREGT | Feb 3, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 31, 2025 (Show all update days)(Hide all update days)- Jan 31, 2025
- Procedures: Opposition procedure, Decision on revocation by EPO has become final, 26.12.2023: changed
- Jan 23, 2025
- Status: changed
- Due date: deleted
- Procedures: Opposition procedure, Revocation by EPO, 26.12.2023: new
- Procedures: Opposition procedure, Decision on revocation by EPO has become final, 26.12.2023: new
- May 15, 2024; May 17, 2023; May 20, 2022; May 18, 2021; Jun 5, 2020; Aug 17, 2019; Jun 5, 2019; Mar 12, 2019; Mar 2, 2019; Jun 15, 2018; May 30, 2018; Jan 9, 2018; Oct 12, 2017; Sep 7, 2017; Jun 13, 2017; Jan 26, 2017; Dec 15, 2016; Nov 15, 2016; Nov 5, 2016; Nov 3, 2016; Oct 20, 2016; Feb 16, 2013
- Historical data not available for this/these date(s)
- Feb 3, 2012
- Date of the first transfer into DPMAregister
|